- News
News
University of Glasgow research could help doctors ‘see’ bowel cancer using imaging technology
Imaging technology could provide a ground-breaking new approach for diagnosing and treating bowel cancer patients, thanks to Cancer Research UK-funded scientists in Glasgow
More
- News
News
Strathclyde student entrepreneurs win award for innovative marketplace idea
An idea to create a marketplace for students to stop wastage of educational resources took top prize at a Strathclyde pitching contest.
More
- News
News
Strathclyde’s £1M project innovates antimicrobial drugs from food by-products
Scientists will use food by-products to make antimicrobial drugs from bacteria, in research led at the University of Strathclyde in collaboration with the University of Surrey and GSK.
More
- News
News
Glasgow’s CardioPrecision leading robotic revolution in cardiac surgery
Glasgow-based MedTech company CardioPrecision has emerged as a key player in advancing the world’s first robotic aortic valve replacement procedure through a tiny incision in the neck, a development that could revolutionise cardiac surgery.
More
- News
News
UWS innovations nominated for prestigious awards
The Awards celebrate exceptional collaborations between businesses and universities, highlighting the positive impact achieved through Knowledge Transfer Partnerships (KTPs).
More
- News
News
Glasgow’s cancer research contributes over £500M to UK Economy
A new report has hailed the strength of patient-centred cancer science in the west of Scotland, estimating that cancer research in Glasgow was worth more than half a billion pounds (£503m) to the UK economy in 2021-22
More
- News
News
Strathclyde Business School launches scale-up initiative with Scottish National Investment Bank
A new programme to address the growth barriers faced by Scottish businesses attempting to scale-up has launched.
More
- News
News
Strathclyde researchers to develop preclinical lead drug for advanced prostate and colorectal cancers
Researchers at the University of Strathclyde have been awarded £2.6 million to develop a preclinical lead drug candidate targeted at advanced prostate and colorectal cancers.
More